StemBioSys manufactures and develops novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. Housed in San Antonio, StemBioSys is led by an experienced management and scientific team.
StemBioSys Inc. is a development-stage biomedical company focused on the isolation and expansion of specialized adult stem cells for clinical use.
Our patented and proprietary technology platforms -- licensed from the University of Texas Board of Regents -- overcome key obstacles to creating clinically useful stem cell therapies.
The centerpiece of our advanced stem cell expansion system is XC-marrow EXM™, a patented "extracellular matrix" laid down by human bone marrow mesenchymal stem cells (MCS).
Development and Collaboration
Producing scalable quantities of multi-potent stem cells creates new hope for treating, and in some cases perhaps even curing, human diseases.